TAMPA, Fla. — Immunotherapy combined with standard chemotherapy significantly improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, according to results. Read More
Phase III Trials ‘Hit a Home Run’ in Advanced Endometrial Cancer – Medpage Today
